+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 28 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are investigating treatments for temporomandibular disorders TMD, which are increasingly common and affect jaw function and cause pain. This study aims to evaluate whether combining manual therapy with vagus nerve stimulation, a nerve linked to pain and jaw function, offers better relief and improved quality of life than manual therapy alone. The study involves 20 participants diagnosed with myogenic TMD, focusing on pain, jaw movement, and distress. Participants are randomly assigned to one of two groups one receiving manual therapy combined with vagus nerve stimulation and the other receiving only manual therapy. Both groups undergo four physiotherapy sessions, one per week over a month, and are trained to continue treatment exercises at home over two months. The manual therapy includes joint manipulation and soft tissue techniques for the jaw. Throughout the study, an independent evaluator will assess participants monthly using questionnaires to measure chronic pain, jaw function, physical symptoms, range of motion, and distress. The main outcomes are changes in health status and chronic pain after two months. This double-blind, randomized study ensures unbiased results by keeping evaluators unaware of group assignments. Participant involvement spans two months of treatment and assessments.

Age: 18Years +All GendersPhase Not Applicable
3 locations
R

Actively Recruiting

Researchers are evaluating the effects of teplizumab compared with a placebo in individuals aged 1 to 25 years who have recently been diagnosed with Stage 3 type 1 diabetes. This Phase 3, multicenter, randomized, double-blind study aims to measure changes in blood sugar control and the ability to reduce prandial insulin use over 52 weeks. Both groups will continue their standard insulin therapy during the study. Participants will receive either teplizumab or a matching placebo through intravenous infusions, with teplizumab doses gradually increasing. The study includes two groups one receiving the study drug and the other receiving placebo infusions. The total study period for each participant lasts about 84 weeks 19 months, during which participants are closely monitored. Throughout the study, participants will be regularly evaluated for blood sugar levels, insulin use, and markers of diabetes control including glycated hemoglobin HbA1c, C-peptide levels, and glucose monitoring. Safety will be assessed by tracking adverse events and immune responses. The research team will monitor participants at specified intervals up to 78 weeks to assess treatment effects and safety.

Age: 1Year - 25YearsAll GendersPhase 3
202 locations
C

Actively Recruiting

Researchers are studying breast cancer patients who have a positive sentinel lymph node after receiving neoadjuvant systemic treatment. The trial evaluates whether axillary radiotherapy ART reduces the risk of lymphedema compared to axillary lymph node dissection ALND in these patients. The study also examines recurrence and overall survival rates, as well as quality of life. This is a prospective, randomized, open-label, parallel group, multicenter study involving approximately 820 patients over 5 years. Participants are divided into two groups one receives axillary radiotherapy without lymphadenectomy, including radiation to levels I and II axilla, level III, supraclavicular area, and possibly the internal mammary chain the other group undergoes axillary lymph node dissection plus radiotherapy to level III, supraclavicular area, and possibly the internal mammary chain. Patients are stratified by neoadjuvant treatment type chemotherapy or hormone therapy. A pilot phase with the first 200 patients has been completed, and interim analysis will be performed. During the study, participants undergo evaluations including imaging by ultrasound or MRI to assess axillary response after neoadjuvant therapy. Researchers will track disease-free survival up to 5 years, overall survival up to 5 years, and incidence of lymphedema up to 3 years after surgery. Quality of life and safety outcomes will also be monitored. The study aims to provide data on whether avoiding lymphadenectomy is a viable option for patients responding well to neoadjuvant treatment.

Age: 18Years +All GendersPhase Not Applicable
61 locations
C

Actively Recruiting

Researchers are evaluating whether adding Quizartinib to the combination of Venetoclax and Azacytidine improves overall survival compared to Venetoclax and Azacytidine alone in adults with newly diagnosed acute myeloid leukemia AML who are not suitable for standard induction chemotherapy due to age, other health conditions, or risk factors. This Phase III trial will randomize participants to compare the two treatment regimens. Participants will be assigned to one of two groups the experimental group will receive Azacytidine as a subcutaneous injection daily on days 1 to 7 of each 28-day cycle, Venetoclax orally daily on days 1 to 7, and Quizartinib orally on days 8 to 21 with dose adjusted by FLT3-ITD mutation status. The standard group will receive Azacytidine daily on days 1 to 7 and Venetoclax daily for 28 days in each 28-day cycle. Treatment continues until disease progression, unacceptable side effects, withdrawal, or other protocol-defined reasons. During the study, participants will have regular clinical visits and follow-up assessments, with survival data collected every three months for two years after the last participant finishes treatment. Researchers will monitor overall survival over four years as the primary outcome, along with event-free survival and complete response rates. Safety and treatment effects will be tracked throughout the study period.

Age: 18Years +All GendersPhase 3
52 locations
E

Actively Recruiting

Researchers are studying the effects of physical exercise on patients diagnosed with Major Depressive Disorder MDD. The trial aims to understand the anti-inflammatory, oxidative stress, and brain mechanisms involved in the antidepressant effects of exercise, as well as the effectiveness of a physical exercise program for MDD patients in real-life conditions. It compares an exercise intervention added to usual antidepressant treatment with standard treatment alone. Participants in the exercise group will follow a 12-week program consisting of daily walking with step goals monitored by an activity band, plus two weekly 60-minute supervised online group sessions combining aerobic and strength exercises. The control group will continue standard antidepressant treatment without changing their usual physical activity. The study includes baseline, 12-week, and one-year follow-up assessments. Throughout the study, participants will undergo clinical evaluations, brain imaging, inflammatory and oxidative stress biomarker testing, cognitive and functioning assessments, and physical fitness measures. Daily activity and sleep will be tracked using wearable devices. Researchers will monitor symptoms and brain changes before, during, and after the intervention to assess the lasting effects of exercise combined with standard treatment.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
5 locations
P

Actively Recruiting

Researchers are evaluating whether adding Hyperthermic Intraperitoneal Chemotherapy HIPEC with Mitomycin C after complete surgical removal of peritoneal metastases in patients with colon cancer affects the chance of cancer returning in the abdomen. This phase IV clinical trial addresses uncertainties from prior research by focusing on the time patients remain free from peritoneal recurrence rather than overall survival. It excludes rectal cancers and patients with extensive peritoneal disease or incomplete surgery to better understand HIPECs role in this setting. Participants are randomly assigned to one of two groups one receiving complete cytoreductive surgery plus HIPEC with Mitomycin C delivered at 35 mgm2 in a heated peritoneal dialysis solution for 90 minutes with dose fractionation, and the other receiving surgery alone without HIPEC. The study corrects previous trial shortcomings by increasing HIPEC infusion time and limiting patient selection based on cancer spread and surgery completeness. During the trial, participants will be monitored for peritoneal recurrence over three years, with assessments including imaging and disease-free survival measures. Researchers will also track postoperative complications within 90 days after surgery and evaluate quality of life at multiple points before surgery, after chemotherapy, and at one and two years. The trial aims to provide detailed information on recurrence patterns, survival, and patient well-being over three years following treatment.

Age: 18Years +All GendersPhase 4
31 locations
C

Actively Recruiting

Subacromial syndrome is a common cause of shoulder pain with unclear causes and no specific treatment. Researchers are evaluating the effectiveness of manual therapy compared to low-medium energy radial shock wave therapy in treating this condition. This randomized, single-blind clinical trial involves 88 participants with subacromial syndrome to compare these two treatment approaches and determine which provides better relief. Participants will be randomly assigned to one of two groups. One group will receive manual therapy focused on joint mobilizations and pressure release of muscle trigger points over 6 weeks. The other group will receive weekly sessions of radial shock wave therapy targeting specific shoulder areas and trigger points, also for 6 weeks. Both groups will complete a 12-week home-based therapeutic exercise program after their initial treatment. Throughout the study, participants will be assessed before treatment and up to one year later. Evaluations include measuring shoulder pain using the visual analogue scale VAS at motion, rest, and overnight. Disability, muscle strength, and shoulder range of motion will also be measured. The study aims to observe changes in these outcomes to compare the effectiveness of the two treatments, with ongoing monitoring and follow-up for up to 12 months after treatment ends.

Age: 18Years - 80YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

The aging process causes changes in organs and tissues that can lead to frailty and a higher risk of falls, which are a major cause of death worldwide. Falls in older adults often result in hospitalization, immobilization, and fear of falling again, which can cause disability. This research aims to better understand how stress affects neuromuscular function, postural control, and balance in elderly people, by exploring the interactions between cognition, stress, and motor control. All participants will undergo a baseline cognitive and physical assessment followed by an experimental session. During the baseline test, they will view low-arousal images from the International Affective Picture System IAPS while performing movements such as standing up, walking, manipulating bottles, and sitting down. In the experimental test, they will repeat these movements while viewing high-arousal IAPS images, with images projected continuously in the background during tasks. Both young and older adults participate, with sub-analyses for elderly individuals based on cognitive impairment and functional dependence. Participants will be monitored using surface electromyography, pressure sensors on the floor, accelerometers, and balance assessments during both tests. Heart rate variability, respiratory rate, and unease levels after viewing images will also be measured. The study involves physical and cognitive assessments before and after image exposure and movement tasks. The total participation duration varies with testing and assessments. This study is sponsored by the University of Alcala.

Age: 18Years - 99YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are conducting a randomized controlled trial to compare two treatments for chronic low back pain CLBP diathermy and dry needling. The study aims to determine if diathermy is more effective than dry needling in reducing pain intensity over the short term. Participants will have chronic non-specific low back pain lasting more than six weeks and will be evaluated on pain, disability, fear of movement, and pain catastrophizing. Participants will be randomly assigned to receive either diathermy treatment or dry needling. Diathermy involves applying a TCaRe Power diathermy instrument to the lumbar region for 10 minutes on each side with massage techniques, while dry needling uses a 4cm needle to target the most painful lumbar muscle areas with 12 incisions followed by a one-minute ischemic compression. Both groups will complete a home exercise program. The study will take place from August 2022 to March 2023. Participants will be assessed at baseline, 1 week, 1 month, and 3 months after treatment. Measurements include pain intensity using a visual analogue scale, disability via the Rolland-Morris questionnaire, fear of movement with the Tampa Scale for Kinesiophobia, pain catastrophizing, and pressure pain threshold. The study uses analysis of variance and moderation analysis to evaluate results, with safety and adherence monitored throughout. Total participation spans approximately three months after treatment.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are investigating how different types of expectations affect the Autonomic Nervous System ANS and pain relief after dry needling treatment in patients with neck pain. The study compares positive, neutral, and negative expectations to see how they influence the bodys response to dry needling, a common therapy for muscle pain. The study focuses on myofascial trigger points in the upper trapezius muscle and explores how patient mindset may impact treatment outcomes. Participants are randomly assigned to one of three groups where they receive positive, neutral, or negative information about dry needling before treatment. All groups receive dry needling applied to the most painful point in the upper trapezius muscle. The study measures changes in pain and ANS activity to understand how expectation influences the bodys reaction to this therapy. During the study, researchers monitor heart rate, breathing rate, skin conductance, and skin temperature before, during, and for 20 minutes after the dry needling treatment. Pain levels are measured using a visual scale and pressure pain threshold tests before and after the intervention. The main outcome is the change in skin conductance 20 minutes after treatment, with additional assessments of heart rate variability and pain intensity. This helps evaluate both nervous system responses and pain relief effects over the course of the study.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location

1-10 of 28

1